Clozaril Logo



CLOZARIL Home

Healthcare Professionals

Professional Main Page

Treatment Requirements
About the CNR
Registration Process
WBC Count and ANC Reporting
and Monitoring Frequency

Frequently Asked Questions

Treatment Support

Dosing Guide

Download Forms & Brochures

Prescribing Information
  Novartis Pharma US

 
Registration Process

A. Individual Prescriber or Medical Director

B. Pharmacy

C. Patient

A. Individual Prescriber or Medical Director

Anyone who wishes to write prescriptions for Clozaril must register with the CNR with the form entitled "Prescriber or Medical Director Registration Form" (download form via the website, www.clozaril.com or call the CNR). The information required for registration includes name, facility name, address, phone number, DEA number, and a signature. The "Medical Director" of a facility may register his/her information by completing this form as well. This will allow any resident or physician with privileges in a given institution (hospital, VAMC, state psychiatric facilities, etc.) to prescribe Clozaril to an in-patient without individually registering him/herself. Once a patient is discharged from that facility, the new prescriber is required to register the patient under his/her DEA number as the current prescriber of record.

Once the form is completed, it can be mailed or faxed to the CNR.

Mailing address:
Novartis Pharmaceuticals Corporation
Clozaril National Registry
One Health Plaza
East Hanover, NJ 07936
Phone: 1-800-448-5938
Fax: 1-800-648-6015
www.clozaril.com

B. Pharmacy

A pharmacist that wishes to dispense Clozaril must have his/her facility/store registered with the CNR, in order to purchase Clozaril from the wholesaler. When a patient presents a prescription for Clozaril, and the patient is new to the pharmacy, the pharmacist must verify that the patient is eligible and registered with the CNR, before dispensing Clozaril. For both new and existing patients, the prescriber must also supply the pharmacist with a current blood work result (drawn within 7 days irrespective of monitoring frequency) prior to dispensing.

Back to Top

C. Patient

The prescriber is responsible for registering any patient for whom s/he is writing prescriptions for Clozaril. The information required in order to register the patient in the CNR, and confirm the patientís eligibility to receive Clozaril or clozapine, are: DEA and Name of prescriber, Initials of the patient, Social Security Number, Date of Birth and Gender.

You can register patient in two ways:
a) by visiting www.clozarilregistry.com and requesting registration on-line OR
b) by calling the CNR at 1-800-448-5938

Once the prescriber and the patient are registered, the prescriber must obtain a WBC and ANC value for the patient. (Please refer to the easy to read chart to determine recommended increased monitoring and required discontinuance of Clozaril).

When a pharmacist receives a prescription for Clozaril for a new patient, the pharmacist must verify that the patient is eligible and registered with the CNR, before dispensing Clozaril. For both new and existing patients, the prescriber must supply the pharmacist with a current blood work result (drawn within 7 days irrespective of monitoring frequency) prior to dispensing.

Back to Top

 
CLOZARIL Home | Professional Main Page | Treatment Requirements
Treatment Support | Dosing Guide | Download Forms & Brochures
Prescribing Information
Site Guide | Contact Us
 
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2014
Novartis Pharmaceuticals Corporation. All rights reserved.